Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.
Journal of internal medicine（2023）
摘要
VEN combined with HMA was effective with R/R AML patients, and the response to treatment was associated with genetic characteristics.
更多查看译文
关键词
genetic characteristics,hypomethylating agents,relapsed or refractory AML,venetoclax
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要